ABSI
Price
$2.62
Change
-$0.21 (-7.42%)
Updated
Aug 19 closing price
Capitalization
391.75M
77 days until earnings call
CNTX
Price
$0.87
Change
-$0.00 (-0.00%)
Updated
Aug 19 closing price
Capitalization
78.36M
77 days until earnings call
Interact to see
Advertisement

ABSI vs CNTX

Header iconABSI vs CNTX Comparison
Open Charts ABSI vs CNTXBanner chart's image
Absci
Price$2.62
Change-$0.21 (-7.42%)
Volume$7.01M
Capitalization391.75M
Context Therapeutics
Price$0.87
Change-$0.00 (-0.00%)
Volume$778.66K
Capitalization78.36M
ABSI vs CNTX Comparison Chart in %
Loading...
ABSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CNTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABSI vs. CNTX commentary
Aug 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABSI is a StrongBuy and CNTX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 20, 2025
Stock price -- (ABSI: $2.62 vs. CNTX: $0.87)
Brand notoriety: ABSI and CNTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABSI: 138% vs. CNTX: 416%
Market capitalization -- ABSI: $391.75M vs. CNTX: $78.36M
ABSI [@Biotechnology] is valued at $391.75M. CNTX’s [@Biotechnology] market capitalization is $78.36M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.19B to $0. The average market capitalization across the [@Biotechnology] industry is $1.82B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABSI’s FA Score shows that 0 FA rating(s) are green whileCNTX’s FA Score has 1 green FA rating(s).

  • ABSI’s FA Score: 0 green, 5 red.
  • CNTX’s FA Score: 1 green, 4 red.
According to our system of comparison, both ABSI and CNTX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABSI’s TA Score shows that 5 TA indicator(s) are bullish while CNTX’s TA Score has 6 bullish TA indicator(s).

  • ABSI’s TA Score: 5 bullish, 5 bearish.
  • CNTX’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, CNTX is a better buy in the short-term than ABSI.

Price Growth

ABSI (@Biotechnology) experienced а -11.78% price change this week, while CNTX (@Biotechnology) price change was +28.46% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.66%. For the same industry, the average monthly price growth was +26.06%, and the average quarterly price growth was +20.46%.

Reported Earning Dates

ABSI is expected to report earnings on Nov 05, 2025.

CNTX is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+2.66% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABSI($392M) has a higher market cap than CNTX($78.4M). ABSI YTD gains are higher at: 0.000 vs. CNTX (-16.810). CNTX has higher annual earnings (EBITDA): -38.29M vs. ABSI (-100.08M). ABSI has more cash in the bank: 117M vs. CNTX (83.5M). CNTX has less debt than ABSI: CNTX (167K) vs ABSI (7.41M). ABSI has higher revenues than CNTX: ABSI (4.14M) vs CNTX (0).
ABSICNTXABSI / CNTX
Capitalization392M78.4M500%
EBITDA-100.08M-38.29M261%
Gain YTD0.000-16.810-
P/E RatioN/AN/A-
Revenue4.14M0-
Total Cash117M83.5M140%
Total Debt7.41M167K4,438%
TECHNICAL ANALYSIS
Technical Analysis
ABSICNTX
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
88%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
88%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
88%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
86%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 8 days ago
90%
Bullish Trend 1 day ago
87%
Declines
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 20 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ABSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CNTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HCGI6.10N/A
N/A
Huntwicke Capital Group Inc.
CHYI0.70N/A
N/A
CHYKINGYOUNG INVT DEV HLDGS INC.
CLEUF0.10N/A
N/A
China Liberal Education Holdings Limited
SNROF44.99N/A
N/A
Sanrio Co. Ltd.
TCHBF202.65N/A
N/A
Tecan AG

ABSI and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABSI has been loosely correlated with RXRX. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if ABSI jumps, then RXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABSI
1D Price
Change %
ABSI100%
-7.42%
RXRX - ABSI
62%
Loosely correlated
-7.79%
CRSP - ABSI
57%
Loosely correlated
-5.96%
BEAM - ABSI
55%
Loosely correlated
-4.39%
ABCL - ABSI
53%
Loosely correlated
-8.14%
NTLA - ABSI
47%
Loosely correlated
-4.10%
More

CNTX and

Correlation & Price change

A.I.dvisor tells us that CNTX and IPSC have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CNTX and IPSC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNTX
1D Price
Change %
CNTX100%
+0.14%
IPSC - CNTX
32%
Poorly correlated
-4.25%
NRIX - CNTX
30%
Poorly correlated
-3.58%
PROK - CNTX
29%
Poorly correlated
-8.27%
ABEO - CNTX
29%
Poorly correlated
-1.01%
ABSI - CNTX
29%
Poorly correlated
-7.42%
More